Streetbeat News

Stock Prices

EXAS

Exact Sciences Corp (NASDAQ:EXAS) reported Q1 earnings with a 6% increase in revenue to $638 million, surpassing estimates but posted a larger-than-expected loss of 60 cents per share. The company's screening and precision oncology revenues also saw year-over-year growth. Despite beating revenue forecasts, the larger loss led to a 16% drop in the stock price after hours. Exact Sciences anticipates full-year 2024 revenue between $2.81 billion and $2.85 billion.

Portfolio Pulse from Adam Eckert

May 08, 2024 | 9:23 pm

ASLE

AerSale (NASDAQ:ASLE) reported Q1 2024 adjusted EPS of $0.11, surpassing the $0.04 estimate, with sales of $90.540M exceeding the $85.424M forecast. This represents a 15.68% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:23 pm

VSEC

VSE Corporation (NASDAQ:VSEC) reported Q1 2024 earnings of $0.87 per share, surpassing the consensus estimate of $0.72 by 20.83%. Sales reached $241.539M, exceeding estimates of $237.207M by 1.83%. These figures represent a 22.54% increase in earnings and a 28.08% increase in sales over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:23 pm

GTBIF

Green Thumb Industries (OTCQX:GTBIF) reported an 11% increase in Q1 2024 revenue to $276 million, with a GAAP net income of $31 million, marking a 240% year-over-year increase. Adjusted EBITDA rose to $91 million, and cash flow from operations increased by 12% to $84 million. The growth is attributed to expanded retail operations and consumer packaged goods sales, including 15 additional RISE Dispensaries and new adult-use sales in Maryland. The company also repurchased 1,067,000 shares for $13.6 million.

Portfolio Pulse from Maureen Meehan

May 08, 2024 | 9:22 pm

SUPN

Supernus Pharmaceuticals (NASDAQ:SUPN) reported Q1 sales of $143.600M, missing the consensus estimate of $145.832M by 1.53% and marking a 6.61% decrease from the previous year's sales of $153.764M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:21 pm

PHX

PHX Minerals reported Q2 2024 results with a GAAP EPS of $(0.01), missing the $0.02 estimate, and sales of $7.869M, below the $8.059M estimate. This represents a significant decrease from the previous year's earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:20 pm

ERF

Enerplus (NYSE:ERF) reported Q1 2024 earnings of $0.32 per share, missing the consensus estimate of $0.33 by 3.03%. Sales were $359.3M, down 18.55% from $441.147M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:20 pm

LSF

Laird Superfood projects its FY24 net sales to be between $38M and $42M, indicating a growth rate of 11-23%.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:19 pm

MMS

Maximus projects its FY24 revenue to be between $5.15B and $5.25B, significantly surpassing the estimated $4.29B.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:18 pm

HL

Hecla Mining (NYSE:HL) reported Q1 2024 GAAP EPS of $(0.01), meeting analyst consensus estimates, with sales of $189.5M surpassing the $188.55M estimate, a 0.50% beat. However, this represents a 5.01% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:18 pm